Neothetics, Inc. (NEOT) Scheduled to Post Earnings on Wednesday

Neothetics, Inc. (NASDAQ:NEOT) is scheduled to be releasing its earnings data before the market opens on Wednesday, November 8th.

Neothetics (NASDAQ:NEOT) last announced its quarterly earnings results on Thursday, August 10th. The biotechnology company reported ($0.20) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.20).

Neothetics, Inc. (NASDAQ NEOT) opened at $1.27 on Monday. Neothetics, Inc. has a 12 month low of $0.30 and a 12 month high of $2.63.

WARNING: “Neothetics, Inc. (NEOT) Scheduled to Post Earnings on Wednesday” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at

Separately, ValuEngine raised Neothetics from a “strong sell” rating to a “sell” rating in a research note on Tuesday, October 17th.

Neothetics Company Profile

Neothetics, Inc is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

Earnings History for Neothetics (NASDAQ:NEOT)

What are top analysts saying about Neothetics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Neothetics Inc. and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit